HanchorBio Inc. (TPE:7827)
108.00
-11.50 (-9.62%)
At close: Nov 19, 2026
HanchorBio Market Cap
HanchorBio has a market cap or net worth of 15.12 billion as of November 19, 2026. It is the 14,552nd most valuable company in the world and the 456th biggest in Taiwan. Its market cap has increased by 88.05% in one year.
Market Cap
15.12B
Enterprise Value
14.00B
Revenue
27.66M
Global Rank
Country Rank
#456 Taiwan
PE Ratio
n/a
ChartMarket Cap Chart
Since June 20, 2025, HanchorBio's market cap has increased from 5.52B to 15.12B, an increase of 173.86%. That is a compound annual growth rate of 103.65%.
| Date | Market Cap | % Change |
|---|---|---|
| Nov 19, 2026 | 15.12B | 31.31% |
| Dec 31, 2025 | 11.51B | 108.56% |
| Jun 20, 2025 | 5.52B | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| TLC BioSciences | 51.82B |
| A-Top Health Biotech | 36.13B |
| Elixiron Immunotherapeutics (Cayman) Limited | 15.84B |
| Obigen Pharma | 7.96B |
| Intelligene | 7.28B |
| Uwell Biopharma | 5.14B |
| Tripartite Therapeutics | 3.82B |
| Pet Pharm Biotech | 2.78B |